Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,959,040
+$1,505,111 QoQ
Shares Held
85,568
+1.7% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#103
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $85,439,394 across 8 Diagnostics & Research names. LH ranks #2 (28.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
158,423 | $30,176,413 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
85,568 | $23,959,040 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
43,021 | $21,569,008 | |
| 4 | ILMN |
Illumina, Inc.
|
28,137 | $4,947,328 | |
| 5 | VCYT |
Veracyte, Inc.
|
62,229 | $3,654,709 | |
| 6 | MYGN |
Myriad Genetics Inc
|
81,392 | $464,748 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,494 | $464,108 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,056 | $204,040 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,959,040 | 85,568 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,453,929 | 84,157 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $21,481,098 | 85,623 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,023,189 | 83,687 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,360,176 | 81,369 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $18,862,646 | 81,046 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,942,455 | 78,242 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $19,599,866 | 87,703 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,787,898 | 77,578 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||